Wed, May 11, 2022

Do Kim Maintained (ABCL) at Buy with Decreased Target to $21 on, May 11th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-21-on-may-11th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Do Kim of Piper Sandler, Maintained "AbCellera Biologics Inc." (ABCL) at Buy with Decreased Target from $28 to $21 on, May 11th, 2022.

Do has made no other calls on ABCL in the last 4 months.



There is 1 other peer that has a rating on ABCL. Out of the 1 peers that are also analyzing ABCL, 0 agree with Do's Rating of Hold.



This is the rating of the analyst that currently disagrees with Do


  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $40 on, Friday, February 25th, 2022